Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© Biochemical Society. Diabetes mellitus is a common long-term condition characterized by raised blood glucose levels secondary to an absolute or relative deficiency of insulin production from the pancreatic islet β-cells. Diabetes is highly heterogeneous in terms of aetiology1, making it a good candidate for stratified medicine approaches. Clinical studies have shown that the standard first-line treatments for Type 1 diabetes (insulin) and Type 2 diabetes (metformin) are not applicable to the rarer monogenic forms of diabetes, so in these cases making a molecular diagnosis can help to direct and optimize treatment.

Type

Journal article

Journal

Biochemist

Publication Date

01/02/2016

Volume

38

Pages

19 - 21